GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 02/09/2010
PIL Zinacef

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 05/06/2006 and displayed until 02/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change from BAN to rINN
  • Change to side-effects
Updated on 31/10/2005 and displayed until 05/06/2006
Reasons for adding or updating:
  • Change to date of revision
  • Company name change or merger
Updated on 29/01/2001 and displayed until 31/10/2005
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   cefuroxime sodium